Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Therapy for Functional Cure of Chronic Hepatitis B
NCT07845058Phase 2Recruiting
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- Oct 2023
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 2, randomised trial in Chronic Hepatitis B (CHB) (2 arms), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Primary endpoints: Serum Hepatitis B surface antigen at 72 weeks, Serum Hepatitis B Virus DNA at 72 weeks and 1 more. Started Oct 2023; status: recruiting.
02
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT07845058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07845058.